Management of Functional Pancreatic Neuroendocrine Neoplasms

被引:0
作者
Ludovica Magi
Matteo Marasco
Maria Rinzivillo
Antongiulio Faggiano
Francesco Panzuto
机构
[1] Sant’Andrea University Hospital,Digestive Disease Unit
[2] ENETS Center of Excellence,Endocrinology Unit
[3] Sant’Andrea University Hospital,Department of Clinical and Molecular Medicine
[4] ENETS Center of Excellence,Department of Medical
[5] Sapienza University of Rome,Surgical Sciences and Translational Medicine
[6] Sapienza University of Rome,undefined
来源
Current Treatment Options in Oncology | 2023年 / 24卷
关键词
Neuroendocrine tumors; Insulinoma; Gastrinoma; Treatment; Somatostatin analogs;
D O I
暂无
中图分类号
学科分类号
摘要
Functional pancreatic neuroendocrine neoplasms (pNENs) are rare and heterogeneous diseases in terms of both clinical and pathological aspects. These tumors secrete hormones or peptides, which may cause a wide variety of symptoms related to a clinical syndrome. The management of functional pNENs is still challenging for clinicians due to the need to control both tumor growth and specific symptoms. Surgery remains the cornerstone in the management of local disease because it can definitively cure the patient. However, when the disease is not resectable, a broad spectrum of therapeutic options, including locoregional therapy, somatostatin analogs (SSAs), targeted therapies, peptide-receptor radionuclide therapy (PRRT), and chemotherapy, are available. The present review summarizes the main key issues regarding the clinical management of these tumors, providing a specific highlight on their therapeutic approach.
引用
收藏
页码:725 / 741
页数:16
相关论文
共 139 条
[1]  
Dasari A(2017)Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States JAMA Oncol 3 1335-1342
[2]  
Shen C(2020)Gastroenteropancreatic neuroendocrine neoplasms: ESMO clinical practice guidelines for diagnosis, treatment and follow-up Ann Oncol 31 844-860
[3]  
Halperin D(2012)ENETS consensus guidelines for the management of patients with digestive neuroendocrine neoplasms: functional pancreatic endocrine tumor syndromes Neuroendocrinology 95 98-119
[4]  
Zhao B(2021)Perspectives on the current pharmacotherapeutic strategies for management of functional neuroendocrine tumor syndromes Expert Opin Pharmacother 22 685-693
[5]  
Zhou S(2012)Neuroendocrine pancreatic tumors: guidelines for management and update Curr Treat Options Oncol 13 24-34
[6]  
Xu Y(2017)Stage IV gastro-entero-pancreatic neuroendocrine neoplasms: a risk score to predict clinical outcome Oncologist 22 409-415
[7]  
Shih T(2020)The functioning side of the pancreas: a review on insulinomas J Endocrinol Invest 43 139-148
[8]  
Yao JC(2016)ENETS consensus guidelines update for the management of patients with functional pancreatic neuroendocrine tumors and non-functional pancreatic neuroendocrine tumors Neuroendocrinology 103 153-171
[9]  
Pavel M(2021)Gastrinoma and Zollinger Ellison syndrome: a roadmap for the management between new and old therapies World J Gastroenterol 27 5890-5907
[10]  
Öberg K(2019)Multidisciplinary management of neuroendocrine neoplasia: a real-world experience from a referral center J Clin Med 8 910-374